Executive Transaction Details
On April 30, 2026, Vita Coco Company, Inc. Executive Chairman Michael Kirban sold 50,000 shares of the company's common stock. The transaction was priced at $68.00 per share, resulting in a total sale value of $3,400,000. According to regulatory filings, these sales were executed under the framework of a Rule 10b5-1 trading plan.
Following this specific transaction, Mr. Kirban's holdings remain substantial through various vehicles. He holds 143,799 shares directly. Additionally, he maintains indirect ownership of 515,681 shares through the Michael Kirban Revocable Trust and another 1,479,049 shares via the Michael Kirban 2010 Trust.
The filings also outlined Mr. Kirban's derivative positions. These include non-qualified stock options to purchase Vita Coco common stock. Specifically, there are fully vested options for 546,000 shares and another tranche of 40,950 shares, both of which carry an exercise price of $10.178 per share. Furthermore, he holds options for a total of 663,973 shares with exercise prices spanning from $15.00 to $32.78. These options are set to vest in annual installments over various timeframes, with expiration dates reaching as far as March 2035.
Fiscal Performance and Market Reaction
The insider activity follows a period of strong financial results for Vita Coco. For the first quarter of fiscal 2026, the company reported sales of $180 million, which represents a 37% increase compared to the previous year. This revenue figure exceeded the expectations set by both Visible Alpha Consensus and BofA Securities.
Profitability also outpaced forecasts. The company reported net income of $30 million, or $0.50 per diluted share, surpassing the anticipated $0.315 per share. Adjusted EBITDA reached $38.7 million, notably higher than the $26.0 million expected by the Street. In light of these results, several analysts have adjusted their outlooks. BofA Securities maintained a Buy rating and raised its price target to $72, while Evercore ISI issued an Outperform rating and increased its price target to $75.
Valuation Context
Despite the positive momentum in earnings, valuation metrics suggest caution. Analysis from InvestingPro indicates that COCO may be overvalued based on Fair Value assessments, noting that the stock is currently trading at a P/E ratio of 37.38.